Creative Planning’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.56M Buy
34,541
+2,577
+8% +$151K ﹤0.01% 1659
2026
Q1
$1.22M Buy
31,964
+1,185
+4% +$37.5K ﹤0.01% 2295
2025
Q4
$672K Sell
30,779
-12,915
-30% -$268K ﹤0.01% 2596
2025
Q3
$938K Buy
+43,694
New +$980K ﹤0.01% 2171
2024
Q4
Sell
-6,827
Closed -$257K 3591
2024
Q3
$257K Buy
6,827
+236
+4% +$9.1K ﹤0.01% 2653
2024
Q2
$261K Sell
6,591
-236
-3% -$7.64K ﹤0.01% 2478
2024
Q1
$229K Buy
6,827
+162
+2% +$5.45K ﹤0.01% 2468
2023
Q4
$222K Buy
+6,665
New +$215K ﹤0.01% 2335
2017
Q1
Sell
-400
Closed -$9K 4640
2016
Q4
$9K Buy
+400
New +$9.65K ﹤0.01% 3594

Other funds holding ATEX

Creative Planning's ATEX Position: Q2 2026 in Review

Creative Planning increased its Anterix (ATEX) stake by 8.1% in Q2 2026, buying an estimated $151K and bringing the position to 34,541 shares worth $3.56M. The position accounts for ﹤0.01% of the portfolio, ranked #1659.

Creative Planning first reported a position in ATEX in Q4 2016 and has held it in 9 quarters since. 172 funds tracked by Wall St. Rank hold ATEX as of Q2 2026.

  • Creative Planning held 34,541 shares of Anterix worth $3.56M as of Q2 2026.
  • Creative Planning bought 2,577 Anterix shares in Q2 2026, an estimated $151K.
  • Anterix made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #1659 holding.
  • Creative Planning first reported a position in Anterix in Q4 2016 and has held it in 9 quarters since.
  • 172 funds tracked by Wall St. Rank held Anterix as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.